Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.45 HKD
789.81 M HKD
7.30 B HKD
598.52 M
About SIMCERE PHARMACEUTICAL GRP LTD
Sector
CEO
Jin Sheng Ren
Headquarters
Nanjing
Website
Founded
1995
ISIN
HK0000658531
FIGI
BBG00XTW3JK8
Simcere Pharmaceutical Group Ltd. engages in the research, development, manufacturing, and sale of pharmaceutical products. It operates through the Sale of Pharmaceutical Products and Promotion Service Income segments. The Promotion Service Income segment includes the rendering promotion service of pharmaceutical products that are not manufactured by the firm. The company was founded by Jin Sheng Ren in 1995 and is headquartered in Nanjing, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 2096 is 6.82 HKD — it has decreased by −1.15% in the past 24 hours. Watch SIMCERE PHARMACEUTICAL GRP LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange SIMCERE PHARMACEUTICAL GRP LTD stocks are traded under the ticker 2096.
2096 stock has fallen by −5.24% compared to the previous week, the month change is a −1.43% fall, over the last year SIMCERE PHARMACEUTICAL GRP LTD has showed a −4.62% decrease.
We've gathered analysts' opinions on SIMCERE PHARMACEUTICAL GRP LTD future price: according to them, 2096 price has a max estimate of 10.02 HKD and a min estimate of 7.42 HKD. Watch 2096 chart and read a more detailed SIMCERE PHARMACEUTICAL GRP LTD stock forecast: see what analysts think of SIMCERE PHARMACEUTICAL GRP LTD and suggest that you do with its stocks.
2096 reached its all-time high on Jul 2, 2021 with the price of 14.98 HKD, and its all-time low was 4.94 HKD and was reached on Feb 5, 2024. View more price dynamics on 2096 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
2096 stock is 1.48% volatile and has beta coefficient of 0.76. Track SIMCERE PHARMACEUTICAL GRP LTD stock price on the chart and check out the list of the most volatile stocks — is SIMCERE PHARMACEUTICAL GRP LTD there?
Today SIMCERE PHARMACEUTICAL GRP LTD has the market capitalization of 17.36 B, it has decreased by −0.56% over the last week.
Yes, you can track SIMCERE PHARMACEUTICAL GRP LTD financials in yearly and quarterly reports right on TradingView.
SIMCERE PHARMACEUTICAL GRP LTD is going to release the next earnings report on Mar 20, 2025. Keep track of upcoming events with our Earnings Calendar.
2096 net income for the last half-year is 494.78 M HKD, while the previous report showed −1.69 B HKD of net income which accounts for 129.36% change. Track more SIMCERE PHARMACEUTICAL GRP LTD financial stats to get the full picture.
Yes, 2096 dividends are paid annually. The last dividend per share was 0.18 HKD. As of today, Dividend Yield (TTM)% is 2.56%. Tracking SIMCERE PHARMACEUTICAL GRP LTD dividends might help you take more informed decisions.
SIMCERE PHARMACEUTICAL GRP LTD dividend yield was 2.61% in 2023, and payout ratio reached 58.03%. The year before the numbers were 1.51% and 42.39% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 5, 2024, the company has 7.03 K employees. See our rating of the largest employees — is SIMCERE PHARMACEUTICAL GRP LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SIMCERE PHARMACEUTICAL GRP LTD EBITDA is 1.18 B HKD, and current EBITDA margin is 12.93%. See more stats in SIMCERE PHARMACEUTICAL GRP LTD financial statements.
Like other stocks, 2096 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SIMCERE PHARMACEUTICAL GRP LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SIMCERE PHARMACEUTICAL GRP LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SIMCERE PHARMACEUTICAL GRP LTD stock shows the neutral signal. See more of SIMCERE PHARMACEUTICAL GRP LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.